Virginia Retirement Systems’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
61,200
+52,800
+629% +$1.56M 0.01% 517
2026
Q1
$233K Buy
+8,400
New +$216K ﹤0.01% 886
2025
Q3
Sell
-76,700
Closed -$864K 1033
2025
Q2
$864K Sell
76,700
-31,900
-29% -$346K 0.01% 609
2025
Q1
$1.1M Buy
+108,600
New +$1.17M 0.01% 539
2023
Q3
Sell
-25,200
Closed -$254K 1019
2023
Q2
$254K Buy
25,200
+12,200
+94% +$109K ﹤0.01% 878
2023
Q1
$95.9K Buy
+13,000
New +$107K ﹤0.01% 1005

Other funds holding ROIV

Virginia Retirement Systems's ROIV Position: Q2 2026 in Review

Virginia Retirement Systems increased its Roivant Sciences (ROIV) stake by 629% in Q2 2026, buying an estimated $1.56M and bringing the position to 61,200 shares worth $2.17M. The position accounts for 0.01% of the portfolio, ranked #517.

Virginia Retirement Systems first reported a position in ROIV in Q1 2023 and has held it in 6 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Virginia Retirement Systems held 61,200 shares of Roivant Sciences worth $2.17M as of Q2 2026.
  • Virginia Retirement Systems bought 52,800 Roivant Sciences shares in Q2 2026, an estimated $1.56M.
  • Roivant Sciences made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #517 holding.
  • Virginia Retirement Systems first reported a position in Roivant Sciences in Q1 2023 and has held it in 6 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.